These data led us to speculate that HMGB1 is associated with the development of postoperative AE-ILD as well as AE-IPF, and thus we hypothesize that baseline levels of circulatory HMGB1 can be a predictive blood marker of this severe complication. Here, HMGB1 is linked to interstitial lung disease.